Company Filing History:
2 out of 79 
2 out of 2 Years Active: 2014-2017
Title: Masayuki Fukumura: Innovator in Viral Vector Technology
Introduction
Masayuki Fukumura is a notable inventor based in Mie, Japan. He has made significant contributions to the field of viral vector technology, particularly in the development of vaccines and gene transfer methods. With a total of 2 patents, his work has the potential to impact medical science and therapeutic applications.
Latest Patents
Fukumura's latest patents include a vaccine prepared utilizing a human parainfluenza virus type 2 vector. This invention discloses a virus vector in which a gene encoding an antigenic polypeptide is integrated into the human parainfluenza virus type 2 gene. The antigenic polypeptide is expressed as a fusion protein with a viral structural protein, allowing for efficient delivery to target cells. Another significant patent is a method for producing a virus vector for gene transfer. This invention describes a cell system that can stably express the F protein and a method for producing an F gene-deficient virus using this cell system.
Career Highlights
Fukumura has worked with esteemed institutions such as Mie University and Biocomo Inc. His research has focused on enhancing the efficacy of viral vectors for therapeutic purposes. His innovative approaches have garnered attention in the scientific community.
Collaborations
Some of his notable coworkers include Mitsuo Kawano and Tetsuya Nosaka. Their collaborative efforts have contributed to advancements in the field of viral vector technology.
Conclusion
Masayuki Fukumura's work in viral vector technology exemplifies the innovative spirit of modern science. His patents and research have the potential to pave the way for new therapeutic strategies in medicine.